L-carnitine reduces lymphocyte apoptosis and oxidant stress in HIV-1-infected subjects treated with zidovudine and didanosine

Antioxidants and Redox Signaling

Volumn 4, Issue 3, 2002, Pages 391-403

  Moretti, Sonia ^a   Marcellini, Sonia ^a   Santini, Gino ^a   Trinchieri, Vito ^a   Lucci, Luciano ^a   Alesse, Edoardo ^a   De Simone, Claudio ^a   Famularo, Giuseppe ^b   Boschini, Antonio ^c  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^c S Patrignano Community   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE; CD4 ANTIGEN; CD8 ANTIGEN; CYCLIN DEPENDENT KINASE 5; DIDANOSINE; FAS ANTIGEN; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEIN P35; SUPEROXIDE; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HYDROGEN PEROXIDE; OXIDIZING AGENT; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; APOPTOSIS; ARTICLE; CELL MEMBRANE POTENTIAL; CELL SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; MITOCHONDRION; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE; VIRUS LOAD; DRUG COMBINATION; DRUG EFFECT; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY;

ANTI-HIV AGENTS; ANTIGENS, CD95; APOPTOSIS; CARNITINE; DIDANOSINE; DRUG THERAPY, COMBINATION; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMAN; HYDROGEN PEROXIDE; MALE; MEMBRANE POTENTIALS; MITOCHONDRIA; OXIDANTS; OXIDATIVE STRESS; PHENOTYPE; REVERSE TRANSCRIPTASE INHIBITORS; SUPEROXIDES; T-LYMPHOCYTES; ZIDOVUDINE; HUMANS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0036019931     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/15230860260196191     Document Type: Article

References (56)

1. Association of cyclin-dependent kinase 5 and its activator p35 with apoptotic cell death
2. Inhibition of tau phosphorylating protein kinase cdk5 prevents beta-amyloid-induced neuronal death
3. The relevance of apoptosis to AIDS pathogenesis
4. Mechanisms of HIV-associated lymphocyte apoptosis
5. Caspase-dependent apoptosis of cells expressing the chemokine receptor CXCR4 is induced by cell membrane-associated human immunodeficiency virus type 1 envelope glycoprotein (gp 120)
6. Early effects of antiretroviral combination therapy on activation, apoptosis and regeneration of T cells in HIV-1-infected children and adolescents
7. Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy
8. Effect of L-carnitine treatment in vivo on apoptosis and ceramide generation in peripheral blood lymphocytes from AIDS patients
9. Mitochondria alterations and dramatic tendency to undergo apoptosis in peripheral blood lymphocytes during acute HIV syndrome
10. Apoptosis and surgical trauma: Dysregulated expression of death and survival factors on peripheral lymphocytes
11. L-carnitine deficiency in AIDS patients
12. Carnitine depletion in peripheral blood mononuclear cells from patients with AIDS: Effect of oral L-carnitine
13. Cell-associated ceramide in HIV-1-infected subjects
14. HIV-1 infection and cellular metabolism
15. Determination of L-carnitine in biological fluids and tissues
16. Influence of L-carnitine on Fas crosslinking-induced apoptosis and ceramide generation in T cell lines: Correlation with its effects on purified acidic and neutral sphingomyelinases in vitro
17. Acetyl-L-carnitine administration increases insulin-like growth factor 1 levels in asymptomatic HIV-1-infected subjects: Correlation with its suppressive effect on lymphocyte apoptosis and ceramide generation
18. Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry
19. Involvement of an ICE-like protease in Fas-mediated apoptosis
20. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis
21. Apoptosis, anti-apoptotic compounds and TNF-α release
22. Cellular dysmetabolism: The dark side of HIV infection
23. Acetyl-carnitine deficiency in AIDS patients with neurotoxicity on treatment with antiretroviral nucleoside analogues
24. Apoptosis control in syncytia induced by the HIV type 1-envelope glycoprotein complex. Role of mitochondria and caspases
25. Apoptosis in AIDS
26. Programmed cell death in peripheral lymphocytes from HIV-infected persons
27. Expression of cyclin-dependent kinase 5 and its activator p35 in rat brain after middle cerebral artery occlusion
28. Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection: Meta-analyses of the randomised evidence
29. The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore
30. Does HIV cause depletion of CD4+ T cells in vivo by the induction of apoptosis?
31. Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity
32. Nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity as an etiology for lipodystrophy
33. Mitochondrial control of apoptosis
34. A cytofluorometric method for the simultaneous detection of both intracellular and surface antigens of apoptotic peripheral lymphocytes
35. Diminished spontaneous apoptosis in lymphocyte from human immunodeficiency virus-infected long-term nonprogressors
36. A family of human cdc2-related protein kinases
37. Effect of L-carnitine on human immunodeficiency virus-1 infection-associated apoptosis: A pilot trial
38. Combined antiviral therapy reduces HIV-1 plasma load and improves CD4 counts but does not interfere with ongoing lymphocyte apoptosis
39. Apoptosis and apoptosis-associated perturbations of peripheral blood lymphocytes during HIV infection: Comparison between AIDS patients and long-term non-progressors
40. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
41. Oxygen-radicals production during ischemia-reperfusion of the lower limbs in man: Inhibitory effects of L-carnitine
42. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration
43. Analysis of the membrane potential of rat- and mouse-liver mitochondria by flow cytometry and possible applications
44. Alteration in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis
45. Both necrosis and apoptosis contribute to HIV-1-induced killing of CD4 cells
46. Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2′, 7′-dichlorofluorescin
47. Azidothymidine induces apoptosis in mouse myeloma cell lines Sp 2/0
48. A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry
49. Elevated resting energy expenditure among HIV-seropositive persons receiving highly active antiretroviral therapy
50. Human immunodeficiency virus type 1 vpr induces apoptosis through caspase activation
51. Cyclin-dependent kinase 5 (Cdk5) and neuron-specific Cdk5 activators
52. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5
53. Toxicity of nucleoside-analogue reverse-transcriptase inhibitors
54. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo
55. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death
56. Cyclin-dependent kinase 5 is associated with apoptotic cell death during development and tissue remodeling